Searched for: subject%3A%22Estrogen%255C%2BReplacement%255C%2BTherapy%22
(1 - 7 of 7)
document
Hellgren, M. (author), Conard, J. (author), Norris, L. (author), Kluft, C. (author), TNO Kwaliteit van Leven (author)
Objective: To study cardiovascular risk markers in women taking estradiol/trimegestone or estradiol/dydrogesterone. Design: Multicenter, randomized, prospective, double-blind study of 184 healthy post-menopausal women randomized to 6 cycles of either estradiol (2 mg) + trimegestone (0.5 mg) (T-group) or estradiol (2 mg) + dydrogesterone (10 mg) ...
article 2009
document
Hemelaar, M. (author), van der Mooren, M.J. (author), Rad, M. (author), Kluft, C. (author), Kenemans, P. (author), TNO Kwaliteit van Leven (author)
Objective: To review the effects of non-oral administration of postmenopausal hormone therapy (HT) on risk markers for atherosclerotic and venous thromboembolic disease.Non-oral postmenopausal HT appears not to increase venous thromboembolic risk, whereas the effect on coronary heart disease risk is less clear. Design: Systematic review of...
article 2008
document
Norris, L.A. (author), Brosnan, J. (author), Bonnar, J. (author), Conard, J. (author), Kluft, C. (author), Hellgren, M. (author), TNO Kwaliteit van Leven (author)
Epidemiological studies have shown that hormone therapy (HT) increases the risk of venous thromboembolism in post menopausal women. The mechanism of this increased risk is unknown; however, activation of the haemostatic system is known to contribute to the pathogenesis of venous thromboembolism. In post-menopausal women the estrogen /progestogen...
article 2008
document
van Baal, W.M. (author), Kenemans, P. (author), Emeis, J.J. (author), Schalkwijk, C.G. (author), Mijatovic, V. (author), van der Mooren, M.J. (author), Vischer, U.M. (author), Stehouwer, C.D.A. (author), Gaubius instituut TNO (author)
Objective: To study the effects of combined hormone replacement therapy on markers of endothelial function and inflammatory activity. Design: Prospective, randomized, controlled study. Setting: Academic hospital. Patient(s): Healthy postmenopausal women with an intact uterus. Intervention(s): For the first 12 months, the hormone replacement...
article 1999
document
Smith-Warner, S.A. (author), Spiegelman, D. (author), Yaun, S.-S. (author), van den Brandt, P.A. (author), Folsom, A.R. (author), Goldbohm, R.A. (author), Graham, S. (author), Holmberg, L. (author), Howe, G.R. (author), Marshall, J.R. (author), Miller, A.B. (author), Potter, J.D. (author), Speizer, F.E. (author), Willett, W.C. (author), Wolk, A. (author), Hunter, D.J. (author), Centraal Instituut voor Voedingsonderzoek TNO (author)
Objective. - To assess the risk of invasive breast cancer associated with total and beverage-specific alcohol consumption and to evaluate whether dietary and nondietary factors modify the association. Data Sources. - We included in these analyses 6 prospective studies that had at least 200 incident breast cancer cases, assessed long-term intake...
article 1998
document
Brussaard, H.E. (author), Gevers Leuven, J.A. (author), Frölich, M. (author), Kluft, C. (author), Krans, H.M.J. (author), Gaubius Instituut TNO (author)
Oestrogen replacement therapy is associated with a decreased risk of cardiovascular disease in postmenopausal women. Patients with non-insulin- dependent diabetes mellitus (NIDDM) have an increased cardiovascular risk. However, oestrogen replacement therapy is only reluctantly prescribed for patients with NIDDM. In a double blind randomized...
article 1997
document
Schaapveld, K. (author), Hirasing, R.A. (author), TNO Preventie en Gezondheid (author)
article 1993
Searched for: subject%3A%22Estrogen%255C%2BReplacement%255C%2BTherapy%22
(1 - 7 of 7)